Parallax | Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21

  • Видео
  • О видео
  • Скачать
  • Поделиться

Parallax | Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21

Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21 – Dr Mirvat Alasnag Watch the full video on Radcliffe Cardiology here: https://www.radcliffecardiology.com/podcasts/parallax-podcast/ep-55-5-interventional-trials-will-change-your-practice-review-esc-21-dr In the second ESC 2021 episode of Parallax, Dr Ankur Kalra’s guest is Dr. Mirvat Alasnag, interventional Cardiologist and Director of Catheterization Laboratory at the King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Dr Alasnag was a programme committee member at this year’s ESC and regional PI of one of the late-breaking trials presented. Ankur invites Mirvat to review the interventional cardiology highlights of the congress. Mirvat summarises the background and latest evidence from the trials and their importance. Ankur and Mirvat discuss the strategies they apply currently and how they think the novel data will guide their decision-making. Trials covered in detail include: STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain? MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode. Guest @mirvatalasnag hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO. Brought to you by Edwards: www.edwardstavr.com Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.
209   |   3 год. назад  |   5 - 0
 

Parallax | Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21

Скачайте изображение (превью) выбрав качество


320x180 480x360 640x480 1280x720

Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21 – Dr Mirvat Alasnag

Watch the full video on Radcliffe Cardiology here:

In the second ESC 2021 episode of Parallax, Dr Ankur Kalra’s guest is Dr. Mirvat Alasnag, interventional Cardiologist and Director of Catheterization Laboratory at the King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Dr Alasnag was a programme committee member at this year’s ESC and regional PI of one of the late-breaking trials presented.

Ankur invites Mirvat to review the interventional cardiology highlights of the congress. Mirvat summarises the background and latest evidence from the trials and their importance. Ankur and Mirvat discuss the strategies they apply currently and how they think the novel data will guide their decision-making.

Trials covered in detail include:
STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?
MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode. Guest @mirvatalasnag hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.
Brought to you by Edwards: www.edwardstavr.com

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.


Parallax | Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21

Чтобы скачать видео "Parallax | Ep 55: 5 Interventional trials that will change your practice: Review of ESC 21" передвинте ползунок вправо



Покажите вашим друзьям, добавьте в соцсети

Ссылка на страницу с видео:

 

Ссылка HTML на страницу с видео:

 

Код для вставки плеера:


  • Комментарии

Комментарии ФБ


Уважаемые друзья!

Источником всего видеоконтента, в том числе проигрывающегося на страницах ресурса ruslar.me, является сторонний видео ресурс, а именно общедоступный видеохостинг YouTube.com, предоставляющий открытый доступ к своему видеоконтенту (используя открытую и общедоступную технологию video API3 youtube.com)!

Проблемы с авторскими правами

Если вам принадлежат авторские права на данное видео, которое было загружено без вашего согласия на YouTube.com, перейдите на страницу этого видео сайта YouTube.com , нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" -> "Нарушение моих прав" и в выпадающем меню, выбирите, что именно нарушается и нажмите кнопку "Отправить".



Неприемлемый контент

Чтобы сообщить о неприемлемом видео, перейдите на YouTube, нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" и выберите в "Сообщить о нарушении" что именно вас не устраивает в этом видео. Подробнее о наших правилах читайте в Условиях использования.